Non-Mitogen-activated protein kinase 7 messenger RNAs with partial complementarity

Non-MAPK7 mRNAs with partial complementarity refers to the diverse set of messenger RNA (mRNA) transcripts that are unintentionally regulated by therapeutic agents designed to target Mitogen-activated protein kinase 7 (MAPK7), also known as ERK5. This phenomenon is a significant challenge in the development of RNA interference (RNAi) and microRNA (miRNA) based therapies, where a small RNA guide strand binds to non-target transcripts through partial sequence matches, primarily involving the 'seed region' (nucleotides 2-8). These off-target interactions can lead to the degradation or translational repression of hundreds of unintended genes, potentially causing cellular toxicity or confounding experimental results by producing phenotypes unrelated to the intended silencing of MAPK7. In the context of MAPK7 research, off-target effects on non-MAPK7 mRNAs have been shown to induce cell cycle arrest and apoptosis, highlighting the need for rigorous specificity controls in oligonucleotide drug design. Consequently, minimizing the impact on these non-MAPK7 mRNAs is a critical safety and efficacy consideration for any RNA-based drug targeting the ERK5 pathway.

Other names

Off-target mRNAsSeed-matched transcriptsNon-specific RNAi targetsmiRNA-like off-targetsNon-MAPK7 mRNAs

RNA interference (RNAi) mediated silencing via partial sequence complementarity, primarily involving seed-mediated binding to the 3' untranslated region (UTR) of unintended transcripts.